Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Tabinda, Saleem"'
Autor:
Iuliia Kovalenko, Tabinda Saleem, Mitali Shah, Sara Seyedroudbari, Konstantin Golubykh, Rimsha Ali, Taaha Mirza, Babray Laek, Ahsan Wahab, Asmi Chattaraj, Ekaterina Proskuriakova, Chandi Garg, Rafiullah Khan
Publikováno v:
Advances in Hematology, Vol 2023 (2023)
Background. Graft-versus-host disease (GVHD) is a potentially fatal complication of allogeneic hematopoietic stem cell transplant. The mainstay of treatment is corticosteroids, which are ineffective in 30–50% of cases. Steroid-refractory GVHD (SR-G
Externí odkaz:
https://doaj.org/article/f5413e37154c4a33ad8c4de78965affb
Autor:
Siddique, Qurashi, Tabinda, Saleem, Iuliia, Kovalenko, Konstantin, Golubykh, Lauren, Holleran
Publikováno v:
American Journal of Case Reports. 23
BACKGROUND Pulmonary cryptococcosis is an uncommon infection mainly affecting immunocompromised individuals. Presentation of cryptococcal disease ranges from asymptomatic pulmonary colonization to severe pneumonia. It can progress to acute respirator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67fa67101aac1346d38b97cca502882a
https://doi.org/10.12659/ajcr.936968
https://doi.org/10.12659/ajcr.936968
Autor:
Tabinda Saleem, Iuliia Kovalenko, Babray Laek, Rimsha Ali, Taaha Muddassir Mirza, Asmi Chattaraj, Ahsan Wahab, Asma Tameez, Hafiz Qurashi, Konstantin Golubykh, Martin Cuevas, Wern Lynn Ng, Yijin Wert, Rafiullah Khan
Publikováno v:
Blood. 140:12898-12899
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68680044bc6d010790d5e2d99fecf956
https://doi.org/10.1182/blood-2022-157632
https://doi.org/10.1182/blood-2022-157632
Autor:
Iuliia Kovalenko, Tabinda Saleem, Babray Laek, Rimsha Ali, Taaha Mirza, Asmi Chattaraj, Ahsan Wahab, Asma Tameez, Hafiz Qurashi, Konstantin Golubykh, Martin Cuevas, Wern Lynn Ng, Yijin Wert, Rafiullah Khan
Publikováno v:
Blood. 140:12895-12896
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ad9daec1e20a7ae6d1ff267eead715a
https://doi.org/10.1182/blood-2022-157624
https://doi.org/10.1182/blood-2022-157624
Autor:
MAIDAH MALIK, HAFIZ MUHAMMAD SIDDIQUE QURASHI, IULIIA KOVALENKO, TABINDA SALEEM, KONSTANTIN GOLUBYKH, TAJ RAHMAN, SANTHOSH GHEEVARGHESE JOHN
Publikováno v:
Chest. 162:A605-A606
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbbb60958302c9da3b5ff2884afd4c61
https://doi.org/10.1016/j.chest.2022.08.473
https://doi.org/10.1016/j.chest.2022.08.473
Autor:
KONSTANTIN GOLUBYKH, IULIIA KOVALENKO, KRIPA RAJAK, NADIM AMMARI, TABINDA SALEEM, HAFIZ MUHAMMAD SIDDIQUE QURASHI
Publikováno v:
Chest. 162:A1579-A1580
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d9a5d36d8ea9b269be9f530059a5de0
https://doi.org/10.1016/j.chest.2022.08.1328
https://doi.org/10.1016/j.chest.2022.08.1328
Publikováno v:
The American Journal of Case Reports
Case series Patients: Female, 72-year-old • Female, 60-year-old • Female, 74-year-old Final Diagnosis: Concurrent breast adenocarcinoma and follicular lymphoma Symptoms: Lymphadenopathy Medication: — Clinical Procedure: — Specialty: Oncology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63e14bb9bc498dd9c1943362432c1013
https://doi.org/10.12659/ajcr.931772
https://doi.org/10.12659/ajcr.931772
Autor:
Iuliia Kovalenko, Konstantin Golubykh, Adan Martin Cuevas Velazquez, Nadim Ammari, Maidah Malik, Manpreet Sandhu, Hafiz Qurashi, Tabinda Saleem, Anas Atrash, Saketram Komanduri, Yijin Wert, Kit Lu
Publikováno v:
Journal of Clinical Oncology. 40:22-22
22 Background: The American Society of Hematology (ASH) Choosing Wisely campaign have created thoughtful conversations between providers and patients in recommending care that is supported by evidence to reduce duplicative testing. However, some have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::beaa2348e87950b629470df5028a8b16
https://doi.org/10.1200/jco.2022.40.28_suppl.022
https://doi.org/10.1200/jco.2022.40.28_suppl.022
Autor:
Iuliia Kovalenko, Tabinda Saleem, Babray Laek, Rimsha Ali, Taaha Muddassir Mirza, Asmi Chattaraj, Ahsan Wahab, Asma Tamez ud din, Hafiz Qurashi, Konstantin Golubykh, Maidah Malik, Rafiullah Khan
Publikováno v:
Journal of Clinical Oncology. 40:e19053-e19053
e19053 Background: Ruxolitinib, an elective Janus Kinase (JAK) 1/2 inhibitor, has been approved by FDA for the treatment of steroid-refractory chronic graft-versus-host-disease (SR cGVHD) after the failure of one or two lines of systemic therapy in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14b0183651b350c39a7c8c737cd81f3c
https://doi.org/10.1200/jco.2022.40.16_suppl.e19053
https://doi.org/10.1200/jco.2022.40.16_suppl.e19053
Publikováno v:
Cureus
A biosimilar is a biochemical product like another already approved biologic agent, known as the reference agent. To be endorsed by the Food and Drug Administration (FDA), biosimilars must demonstrate that they are as safe and effective as their refe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d17be04907040a272510bf89cddc54c0
https://doi.org/10.7759/cureus.9300
https://doi.org/10.7759/cureus.9300